- Home
- MNKD vs UFCS Comparison
MNKD vs UFCS Comparison
Compare MNKD & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNKD | UFCS |
|---|---|---|
| Founded | 1991 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.6M | 936.4M |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MNKD | UFCS |
|---|---|---|
| Price | $2.72 | $39.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $8.56 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 4.5M | 83.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | ★ 87.45 |
| EPS | 0.02 | ★ 4.48 |
| Revenue | $348,966,000.00 | ★ $1,386,412,000.00 |
| Revenue This Year | $35.81 | $11.80 |
| Revenue Next Year | $11.89 | $8.77 |
| P/E Ratio | $138.50 | ★ $8.75 |
| Revenue Growth | ★ 22.23 | 10.62 |
| 52 Week Low | $2.23 | $25.81 |
| 52 Week High | $6.51 | $40.63 |
Technical Indicators
Market Signals| Indicator | MNKD | UFCS |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 58.50 |
| Support Level | $2.52 | $35.78 |
| Resistance Level | $4.09 | $39.43 |
| Average True Range (ATR) | 0.11 | 0.91 |
| MACD | 0.11 | 0.19 |
| Stochastic Oscillator | 88.99 | 77.16 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.